Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: A 3-arm randomized phase II trial.

BACKGROUND Antalgic radiotherapy for bone metastases might be improved by implementing biological information in the radiotherapy planning using (18)F-FDG-PET-CT based dose painting by numbers (DPBN). MATERIALS AND METHODS Patients with uncomplicated painful bone metastases were randomized (1:1:1) and blinded to receive either 8Gy in a single fraction with conventionally planned radiotherapy (arm A) or 8Gy in a single fraction with DPBN (dose range between 610Gy and 10Gy) (arm B) or 16Gy in a single fraction with DPBN (dose range between 1410Gy and 18Gy) (arm C). The primary endpoint was overall pain response at 1month. The phase II trial was designed to select the experimental arm with sufficient promise of efficacy to continue to a phase III trial. RESULTS Forty-five patients were randomized. Eight (53%), 12 (80%) and 9 patients (60%) had an overall response to treatment in arm A, B and C, respectively. The estimated odds ratio of overall response for arm B vs. A is 3.5 (95% CI: 0.44-17.71, p=0.12). The estimated odds ratio of arm C vs. A is 1.31 (95% CI: 0.31-5.58, p=0.71). CONCLUSION A single fraction of 8Gy with DPBN will be further evaluated in a phase III-trial.

[1]  D. Loeffelbein,et al.  Performance of Whole-Body Integrated 18F-FDG PET/MR in Comparison to PET/CT for Evaluation of Malignant Bone Lesions , 2014, The Journal of Nuclear Medicine.

[2]  Søren M Bentzen,et al.  Theragnostic imaging for radiation oncology: dose-painting by numbers. , 2005, The Lancet. Oncology.

[3]  F. Stewart,et al.  Milestones in normal tissue radiation biology over the past 50 years: From clonogenic cell survival to cytokine networks and back to stem cell recovery , 2009, International journal of radiation biology.

[4]  Yong Xu,et al.  Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy , 2011, European Radiology.

[5]  F. Calabria,et al.  Metabolic and clinical assessment of efficacy of cryoablation therapy on skeletal masses by 18F-FDG positron emission tomography/computed tomography (PET/CT) and visual analogue scale (VAS): initial experience , 2011, Skeletal Radiology.

[6]  C. Cleeland,et al.  Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. , 2007, Journal of neurosurgery. Spine.

[7]  Jingeng Zhu,et al.  Image‐guided and intensity‐modulated radiosurgery for patients with spinal metastasis , 2003, Cancer.

[8]  Joshua D. Lawson,et al.  A survey of stereotactic body radiotherapy use in the United States , 2011, Cancer.

[9]  Xiaoyuan Chen,et al.  PET Imaging of Inflammation Biomarkers , 2013, Theranostics.

[10]  T. Boterberg,et al.  Pain control by ionizing radiation of bone metastasis. , 2004, The International journal of developmental biology.

[11]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[12]  T. Reichert,et al.  Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. , 2003, Oral oncology.

[13]  John Whitehead,et al.  One‐ and two‐stage design proposals for a phase II trial comparing three active treatments with control using an ordered categorical endpoint , 2009, Statistics in medicine.

[14]  S. Bentzen.  Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology , 2006, Nature Reviews Cancer.

[15]  A. Scarsbrook,et al.  FDG PET/CT in oncology: "raising the bar". , 2010, Clinical radiology.

[16]  C. Rübe,et al.  Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  J. Rock,et al.  Pain control by image-guided radiosurgery for solitary spinal metastasis. , 2008, Journal of pain and symptom management.

[18]  P. Hoskin,et al.  Stereotactic body radiotherapy for spinal and bone metastases. , 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

[19]  M. Adli,et al.  FDG PET uptake as a predictor of pain response in palliative radiation therapy in patients with bone metastasis. , 2013, Radiology.

[20]  N. Willich,et al.  FDG-PET/CT in oncology , 2007, Nuklearmedizin.

[21]  J. Flickinger,et al.  Clinical practice of image-guided spine radiosurgery - results from an international research consortium , 2011, Radiation oncology.

[22]  Scott Soltys,et al.  International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. , 2012, International journal of radiation oncology, biology, physics.

[23]  Liying Zhang,et al.  Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers. , 2009, International journal of radiation oncology, biology, physics.

[24]  James M Galvin,et al.  Intensity modulating and other radiation therapy devices for dose painting. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Nick Jagiella,et al.  Estimating Dose Painting Effects in Radiotherapy: A Mathematical Model , 2014, PloS one.

[26]  H. Thierens,et al.  [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  H. Lam,et al.  Single fraction conventional external beam radiation therapy for bone metastases: a systematic review of randomised controlled trials. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  Sunil Krishnan,et al.  Targeting inflammatory pathways for tumor radiosensitization. , 2010, Biochemical pharmacology.

[29]  B. Jeremic,et al.  A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. , 1998, International journal of radiation oncology, biology, physics.

[30]  Fang-Fang Yin,et al.  RTOG 0631 Phase II/III Study of Image-Guided Stereotactic Radiosurgery for Localized (1-3) Spine Metastases: Phase II Results. , 2011, International journal of radiation oncology, biology, physics.

[31]  Ehud Mendel,et al.  A Novel Classification System for Spinal Instability in Neoplastic Disease: An Evidence-Based Approach and Expert Consensus From the Spine Oncology Study Group , 2009, Spine.

[32]  Y. M. van der Linden,et al.  Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. , 2012, International journal of radiation oncology, biology, physics.

[33]  P. Hoskin,et al.  International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  E. Yorke,et al.  Use of normal tissue complication probability models in the clinic. , 2010, International journal of radiation oncology, biology, physics.

[35]  You Lu,et al.  Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local Control in Non–Small-Cell Lung Cancer Receiving Radiotherapy , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[36]  L. Rhines,et al.  Irradiation of spinal metastases: should we continue to include one uninvolved vertebral body above and below in the radiation field? , 2011, International journal of radiation oncology, biology, physics.

[37]  E. Noordijk,et al.  Comparative analysis of risk factors for pathological fracture with femoral metastases. , 2004, The Journal of bone and joint surgery. British volume.

[38]  P. Brown,et al.  Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. , 2012, The Lancet. Oncology.